Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Ayad Ahmed Hussein"'
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 6, Iss 1, Pp e2014019-e2014019 (2014)
Abstract Background: Cord blood transplant is an accepted treatment for many malignant and non-malignant diseases. We sought to determine the feasibility of collecting cord blood in Jordan and the effect of maternal and fetal factors on the quality o
Externí odkaz:
https://doaj.org/article/8af2980e3b78402f955c10c5c15ebc89
Autor:
Said Benchekroun, Hassan El-Solh, Mohamed Bayoumy, Tarek Ben Othman, Ardeshir Ghavamzadeh, Amir Ali Hamidieh, Saloua Ladeb, Amr Nassar, Alaa Elhaddad, Fazal Hussain, Salman Naseem Adil, Mahmoud Aljurf, Mani Ramzi, Ahmed Alsagheir, Amal Al-Seraihy, Mohamed Amine Bekadja, Fawzi Abdel-Rahman, Ayad Ahmed Hussein, Ahmed Nacer Redhouane, Ali Bazarbachi, Rose Marie Hamladji, Salam Alkindi, Parvez Ahmed, Abdulaziz Alabdulaaly, Walid Rasheed, Reem Al-Sudairy, Syed Osman Ahmed, Ahmed Ibrahim, David Dennison, Omar Fahmy
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 8, Iss 4, Pp 167-175 (2015)
Objective/Background: The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) group has accumulated over 31 years of data and experience in hematopoietic stem cell transplantation (HSCT), particularly in hemoglobinopathies, severe aplastic
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S129
Introduction Central venous catheter (CVC) access is an essential component of pediatric hematopoietic stem cell transplant (HSCT). Long-term CVC access is associated with an increased risk of infection and device dysfunction. Studies have shown that
Autor:
Magnus Nordenskjöld, Cecilia Langenskiöld, Marie Meeths, Sule Unal, Yenan T. Bryceson, Zehra Fadoo, Bianca Tesi, João Pinho Silva, Jan-Inge Henter, Samuel C. C. Chiang, Rabia Muhammad Wali, Ayad Ahmed Hussein, Ramón Lecumberri, Dalia H. El-Ghoneimy
Publikováno v:
Pediatric Blood & Cancer. 62:2094-2100
Background Perforin, encoded by PRF1, is a pore-forming protein crucial for lymphocyte cytotoxicity. Biallelic PRF1 nonsense mutations invariably result in early-onset hemophagocytic lymphohistiocytosis (HLH), termed familial HLH type 2 (FHL2). In co
Autor:
Ayad Ahmed Hussein, Nilly N. Hussein, Enas F. Younis, OmarZ. Al-Rawi, Fawzi Abdel-Rahman, Abdulhadi Al-Zaben, Husam Abujazar, Adnan Saad
Publikováno v:
Journal of Endocrinology and Diabetes. 3:01-03
Publikováno v:
Pediatric Transplantation. 18:625-630
There are limited data on the optimal dosing and schedule of G-CSF priming prior to BM harvest. We evaluated the safety and efficacy of three days of G-CSF of primed BM from related pediatric donors. Forty-five children were treated. All donors recei
Autor:
Jennifer Domm, Julie Isbell, Katie Bruce, Haydar Frangoul, Misty Evans, Darren Johnson, Leigh Greer, Ayad Ahmed Hussein
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S120
Introduction Allogeneic HSCT (alloHSCT) offers a potential cure for patients with AML; however, 40% of AML patients receiving alloHSCT will experience relapsed disease. Second alloHSCT can offer the best long-term survival but is associated with sign
Publikováno v:
Pediatric Transplantation. 17:815-819
IMF is a rare disease in children that can present during infancy and has a protracted course. The only known curative approach for this disease in adult patients is allogeneic HSCT. There are very few reports describing the long-term outcome of youn
Autor:
Ayad Ahmed Hussein, Hadeel Halalsheh, Khaldoun Alkayed, Faris Madanat, Khadra Salami, Maha Riziq
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 6, Iss 1, Pp 34-41 (2013)
Background: Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) remained until recently the molecular genetic abnormality associated with the worst outcome. Hematopoietic stem cell transplant (HSCT) was considered the treatment of
Autor:
Ayad Ahmed Hussein, Rula Najjar, Husam Abujazar, Fawzi Abdel-Rahman, Lubna Ghatasheh, Tuka Hammada, Abdulhadi Al-Zaben, Shanta Sharma, Haydar Frangoul, Abeer Natsheh
Publikováno v:
Pediatric Blood & Cancer. 60:1345-1349
Background Patients with thalassemia in developing countries have limited access to safe transfusions, regular medical care and chelation therapy. Although allogeneic hematopoietic stem cell transplantation (HSCT) can offer a curative approach, there